How to Present Flow Cytometry Data in a Publication

Flow cytometry is a widely-used laser-based technique that can be used to measure and quantify cell size, cell granularity, cellular markers, and intracellular components such as proteins and nucleotides. This analytical technique provides simultaneous multi-parameter analysis that can be used to support conclusions in scientific publications.

cells for analysis using flow cytometry - an illustration By Peeradach RPeeradach R | Shutterstock

Essential factors to consider before publishing flow cytometry data

Experimental set up and sample preparation

Prior to submitting a publication, it is crucial that the authors include a detailed description of the experimental design. This description should include the number of independent experiments that were performed during the course of the study and number of samples analyzed during each experiment. Preparation of the samples or cells suspensions analyzed by flow cytometry must also be explained.

Flow cytometry preparation methods include the use of specific proteases for the isolation, filtration and lysis of any particular cell type, as well as permeabilization and fixation reagents. This information ensures reproducibility and assists other researchers in future experiments.

Data acquisition

The methodology and parameters used for flow cytometry data acquisition should include the equipment’s manufacturer, model, software, lasers and laser power settings, as well as the optical emission filters that were used for each fluorescent reagent.

Compensation or mathematical correction processes to eliminate spectral overlap between the fluorochromes must also be described. Furthermore, the exact masking strategies, such as use of certain software features also improve reproducibility of experiments.

Sample size or number of cells counted in the population of interest and the minimum number of events for a target population must also be indicated.

Analysis of the data obtained and presentation

Careful data analysis of the vast amount of information obtained from flow cytometry is a crucial part of any publication.

Gating schemes

When describing gating schemes, aspects such as light scatter gates, live-dead gates, doublet gates and fluorescence-detecting gates must be addressed.

Defining thresholds

It is critical that authors include all information regarding controls that were used. These include unstained, biological, isotype, fluorescence minus-one or negative controls present within the cell suspension.

Statistical analysis

Statistical analysis, including whether the data represents a comparison among a mean, median or percentage, should also be included.

Presenting data

Authors may choose various presentation styles, such as dot or density plots, to highlight the cell population of interest. When considering dot plots, it is important to label both axes and include whether a linear or logarithmic scale is being used.

It also recommended that the antibodies or fluorophores are directly labeled in the plot. Percentages should be listed in gates, whereas the number of total events in a plot should be indicated in the plot or figure legend.

Standardization in flow cytometry data

Despite the wide range of flow cytometry applications, this technique has been scrutinized on its reproducibility due to lack of standard methods to accurately compare flow cytometry data.

The complexity of the data warrants the need for minimum standards. Flow cytometry researchers would also benefit from a more formalized framework for this technique, including guidelines on experimental and sample information, acquisition, analysis, and presentation of data.

Conclusion

To improve the reproducibility of data obtained from flow cytometric analysis and make it easy to understand for readers, it is essential to include detailed explanations of how the analysis was performed. By including this information, researchers can easily validate the quality of data and conclusion drawn.

Further Reading

Last Updated: Apr 3, 2019

Benedette Cuffari

Written by

Benedette Cuffari

After completing her Bachelor of Science in Toxicology with two minors in Spanish and Chemistry in 2016, Benedette continued her studies to complete her Master of Science in Toxicology in May of 2018. During graduate school, Benedette investigated the dermatotoxicity of mechlorethamine and bendamustine; two nitrogen mustard alkylating agents that are used in anticancer therapy.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cuffari, Benedette. (2019, April 03). How to Present Flow Cytometry Data in a Publication. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/life-sciences/How-to-Present-Flow-Cytometry-Data-in-a-Publication.aspx.

  • MLA

    Cuffari, Benedette. "How to Present Flow Cytometry Data in a Publication". News-Medical. 21 December 2024. <https://www.news-medical.net/life-sciences/How-to-Present-Flow-Cytometry-Data-in-a-Publication.aspx>.

  • Chicago

    Cuffari, Benedette. "How to Present Flow Cytometry Data in a Publication". News-Medical. https://www.news-medical.net/life-sciences/How-to-Present-Flow-Cytometry-Data-in-a-Publication.aspx. (accessed December 21, 2024).

  • Harvard

    Cuffari, Benedette. 2019. How to Present Flow Cytometry Data in a Publication. News-Medical, viewed 21 December 2024, https://www.news-medical.net/life-sciences/How-to-Present-Flow-Cytometry-Data-in-a-Publication.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Potential new mRNA-based therapy for pre-eclampsia